1 Table of Contents: “..., Evaluation, Research, Learning and Adapting (MERLA) -- Key indicators for NTDs -- NTD indicator selection...”

2 Subjects: “...Vaccines / Research...”

3 Table of Contents: “...Evidence-based practice (EBP) -- Reducing problem behavior -- Opportunities and barriers...”

4 Table of Contents: “...Quality and validity in animal model research are issues of scientific and ethical relevance...”

5 Subjects: “...Pharmaceutical Research / methods...”

6 Subjects: “...Pharmaceutical Research / methods...”

7 “...Solution proposed to a two hundred year old problem in oncology...”

8 Subjects: “...Pharmaceutical Research...”

9 Table of Contents: “...Randomized cancer clinical trials paradigm problems -- Novel paradigm changes in cancer management...”

10 Table of Contents: “... -- Current consensus & the importance of randomization -- Generalizability: problems with N-of-1 clinical...”

11 Table of Contents: “... -- Relapses -- Specific treatments for specific problems...”

12 Table of Contents: “..., the "multiple testing problem" and the permutation procedure...”

13 Table of Contents: “...Pre-processing data analysis -- Metabolomics bottleneck & the "cocktail party problem" -- From raw...”

14 Table of Contents: “...Scope of the dengue problem -- Assessing the need for a tetravalent vaccine -- In-depth look...”

15 Table of Contents: “... warfare programs -- Development of the principles of biosafety -- Relationship to emerging infectious...”

16 Table of Contents: “... leadership -- Pharmaceutical industry -- Funding -- Patient care -- Industry partnership program -- Health...”

17 Table of Contents: “...Contents: COVID-19 disease outcomes in elderly compared to younger adults -- Extent of the problem...”

18 Table of Contents: “...An experiment in science policy: the ethical, legal and social implications (ELSI) program...”

19 Table of Contents: “...Principles of how to sequence and progress a functional rehabilitation program for an individual...”

20 Table of Contents: “... program identify how disease affects patients daily lives -- New therapeutic options present new...”